ChiCTR2200059782 版本V1.0 版本创建时间2022/05/11 15:40:57 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200059782 

最近更新日期:

Date of Last Refreshed on:

2022-05-11 15:40:52 

注册时间:

Date of Registration:

2022-05-11 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

请与我们联系上传伦理审查文件;请完善测量指标的填写。 妊娠期糖尿病母胎基因及代谢研究

Public title:

Maternal-fetal genes and metabolism of gestational diabetes mellitus

注册题目简写:

English Acronym:

研究课题的正式科学名称:

胎儿TCF7L2 的基因多态性在妊娠期糖尿病中的相关性研究

Scientific title:

Fetal TCF7L2 gene polymorphism in gestational diabetes mellitus

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

方畅平 

研究负责人:

吴玲玲 

Applicant:

Changping Fang 

Study leader:

Lingling Wu 

申请注册联系人电话:

Applicant telephone:

18122785265

研究负责人电话:

Study leader's
telephone:

18922103425

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

fcp07041601@163.com

研究负责人电子邮件:

Study leader's E-mail:

wulingling2003@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市黄埔区萝岗和苑H6-1204

研究负责人通讯地址:

广东省广州市天河区天河路600号

Applicant address:

H6-1204 luogang Heyuan, Huangpu District, Guangzhou city, Guangdong Province

Study leader's address:

No. 600 Tianhe Road, Tianhe District, Guangzhou

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中山大学附属第三医院

Applicant's institution:

The Third Affiliated Hospital Sun Yat-sen University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

中大附三医伦[2018]02-368-01

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

中山大学附属第三医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

黄桂珍

Contact Name of the ethic committee:

Guizhen Huang

伦理委员会联系地址:

广东省广州市天河区天河路600号

Contact Address of the ethic committee:

No. 600 Tianhe Road, Tianhe District, Guangzhou

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中山大学附属第三医院

Primary sponsor:

The Third Affiliated Hospital of Sun Yat-sen University

研究实施负责(组长)单位地址:

广东省广州市天河区天河路600号

Primary sponsor's address:

No. 600 Tianhe Road, Tianhe District, Guangzhou

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangzhou

City:

Guangzhou

单位(医院):

中山大学附属第三医院

具体地址:

天河区天河路600号

Institution
hospital:

The Third Affiliated Hospital of Sun Yat-sen University

Address:

600 Tianhe Road, Tianhe District

经费或物资来源:

广东省科学技术厅

Source(s) of funding:

Guangdong Provincial Department of Science and Technology

研究疾病:

妊娠期糖尿病  

Target disease:

Gestational diabetes

研究疾病代码:

Target disease code:

研究类型:

病因学/相关因素研究

Study type:

Cause/Relative factors study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

妊娠期糖尿病是围产期最常见的并发症之一,孕期会严重影响母婴健康,产后也会增加母婴发生糖尿病、肥胖的风险。因此,我们开展此项研究,通过分析母婴基因型及代谢情况,为早期诊断妊娠期糖尿病、改善妊娠期糖尿病治疗提供依据,并据此建立新生儿糖尿病易感基因资料库,为子代出生后的营养方式提供科学指导,从而降低子代日后2 型糖尿病的发生率  

Objectives of Study:

Gestational diabetes is one of the most common complications in perinatal period, which will seriously affect maternal and infant health during pregnancy and increase the risk of diabetes and obesity after delivery. Therefore, we carried out the study, by analyzing the maternal genotype and metabolism, for early diagnosis of gestational diabetes, the improvement of gestational diabetes treatment, and to establish neonatal diabetes susceptibility genes database, and provide scientific guidance for children nutrition after birth way, so as to reduce the incidence of children with type 2 diabetes in the future

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

孕期通过OGTT诊断为妊娠期糖尿病及非妊娠期糖尿病的健康孕妇

Inclusion criteria

Pregnant women with gestational diabetes and healthy pregnant women

排除标准:

已确诊1 型、2 型糖尿病及其他内分泌代谢性疾病等孕妇

Exclusion criteria:

Pregnant women have been diagnosed with type 1, type 2 diabetes and other endocrine and metabolic diseases

研究实施时间:

Study execute time:

From 2022-04-28 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-04-28 00:00:00 To 2024-12-31 00:00:00

干预措施:

Interventions:

组别:

1组

样本量:

250

Group:

Group 1

Sample size:

干预措施:

干预措施代码:

Intervention:

Intervention code:

组别:

2组

样本量:

250

Group:

Group 2

Sample size:

干预措施:

干预措施代码:

Intervention:

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangzhou

City:

单位(医院):

中山大学附属第三医院 

单位级别:

三甲 

Institution
hospital:

The Third Affiliated Hospital of Sun Yat-sen University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

基因型

指标类型:

主要指标

Outcome:

genotype

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

外周血

组织:

Sample Name:

Peripheral blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

脐带血

组织:

Sample Name:

Umbilical cord blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

研究者采用随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

The researchers used a random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

http://rdd.sysu.edu.cn

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

http://rdd.sysu.edu.cn

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

研究者收集数据并记录

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Researchers collect data and record it in a book

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-05-11 15:40:52